TorqPenderloin
Well-Known Member
The four studies you cited specifically note the long-term effects of Glibenclamide (Glyburide). We are specifically discussing Gliclazide in this case.It is a relatively easy fact to confirm with a bit of research.
I could counter all four studies with one (or two) that specifically compares Gliclazide to Glibenclamide:
https://www.researchgate.net/public...poptosis_induced_by_intermittent_high_glucose
This study compares several different types of sulfonylureas and specifically notes glibenclamide as an outlier in comparison:
http://www.who.int/selection_medicines/committees/expert/19/applications/Sulfonylurea_18_5_A_R.pdf
I'll stick to my original statement in saying that I have yet to see any PROOF to support the theory.